Briefly, SMAD4 deletion enhanced PAC pathogenesis directed by KRAS mutation, but also altered the tumor phenotype: tumors with SMAD4 deficiency were well-to-moderately differentiated and expressed epithelial markers, whereas tumors with intact SMAD4 frequently exhibited markers of EMT. Here, SMAD4 is linked to gonorrhea.